These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


902 related items for PubMed ID: 14657694

  • 1. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H, Heslan M, Usal C, Amigorena S, Cuturi MC.
    Transplantation; 2003 Nov 27; 76(10):1503-10. PubMed ID: 14657694
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S, Flamand V, Goldman M, Braun MY.
    Transplantation; 2003 Feb 15; 75(3):407-13. PubMed ID: 12589166
    [Abstract] [Full Text] [Related]

  • 3. Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats.
    Yang X, Meng S, Jiang H, Zhu C, Wu W.
    J Surg Res; 2011 Dec 15; 171(2):826-32. PubMed ID: 20828738
    [Abstract] [Full Text] [Related]

  • 4. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H, Leamer M, Wang HK, Makowka L, Cramer DV.
    Transplantation; 1995 Feb 15; 59(3):401-10. PubMed ID: 7871571
    [Abstract] [Full Text] [Related]

  • 5. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
    DePaz HA, Oluwole OO, Adeyeri AO, Witkowski P, Jin MX, Hardy MA, Oluwole SF.
    Transplantation; 2003 Feb 27; 75(4):521-8. PubMed ID: 12605121
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC, Josien R, Cantarovich D, Bugeon L, Anegon I, Menoret S, Smit H, Douillard P, Soulillou JP.
    Eur J Immunol; 1994 Jul 27; 24(7):1627-31. PubMed ID: 8026523
    [Abstract] [Full Text] [Related]

  • 8. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM, Waller EK.
    Biol Blood Marrow Transplant; 2004 Aug 27; 10(8):540-51. PubMed ID: 15282532
    [Abstract] [Full Text] [Related]

  • 9. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R, Sacks JM, Unadkat JV, Solari M, Horibe EK, Thomson AW, Lee AW, Feili-Hariri M.
    Transplantation; 2008 Jan 27; 85(2):237-46. PubMed ID: 18212629
    [Abstract] [Full Text] [Related]

  • 10. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ, Izycki DM, Zielinski M.
    Transplantation; 2003 Dec 27; 76(12):1662-8. PubMed ID: 14688512
    [Abstract] [Full Text] [Related]

  • 11. [Impact of novel negative immunoregulatory dendritic cells on regulatory T cells in cardiac allograft recipient rats].
    Zheng DH, Shi BY, Zou YP, Cai M, Qian YY, Hong BF, Dou LP, Li L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan 27; 26(1):13-7. PubMed ID: 20056079
    [Abstract] [Full Text] [Related]

  • 12. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Yoder B, Siemionow M.
    Transplant Proc; 2006 Jun 27; 38(5):1625-33. PubMed ID: 16797371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N, Guo Z, Dong Y, Newton-West M, Adams AB, Lee ED, Wang J, Pearson TC, Larsen CP, Newell KA.
    Transplantation; 2006 Feb 15; 81(3):455-62. PubMed ID: 16477234
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR, Wegmann KW, Zhao RW, Hickey WF.
    J Autoimmun; 2000 Nov 15; 15(3):369-79. PubMed ID: 11040077
    [Abstract] [Full Text] [Related]

  • 16. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM, Lu L, Tao R, Harnaha J, Fung JJ, Huang LT, Qian S.
    Transplant Proc; 2004 Jun 15; 36(5):1592-4. PubMed ID: 15251391
    [Abstract] [Full Text] [Related]

  • 17. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents.
    Alfrey EJ, Wang X, Lee L, Holm B, Kim J, Adams G, Dafoe DC.
    Transplantation; 1995 Apr 27; 59(8):1171-6. PubMed ID: 7732564
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J, Priestley C, Fabre J, Chevalier S, van der Meide P, Schellekens H, Jacques Y, Soulillou JP.
    J Heart Lung Transplant; 1991 Apr 27; 10(3):424-30. PubMed ID: 1906747
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 46.